The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia
Crossref DOI link: https://doi.org/10.1007/s12325-019-00914-9
Published Online: 2019-03-11
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lu, Ju-Ming
Funding for this research was provided by:
Sanofi China
Text and Data Mining valid from 2019-03-11
Article History
Received: 3 January 2019
First Online: 11 March 2019